E2A-PBX1 exerts its inhibitory apoptosis, promotional clonogenesis, enhanced migration, increased drug resistance, and immune evasion functions by regulating target genes, thus increasing the malignancy of ALL (Figure 3B). This evidence concerns the gene PBX1 and acute lymphoblastic leukemia.